Benno Rattel

USPTO Granted Patents = 15 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 9.4

ph-index = 6

Forward Citations = 152(Granted Patents)

Company Filing History:

6 out of 75

Amgen Research (munich) Gmbh

Astellas Deutschland Gmbh

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428491 - PSMA and CD3 bispecific T cell engaging antibody constructs (2025-09-30),

2. 11661462 - Optimized cross-species specific bispecific single chain antibody contructs (2023-05-30),

3. 11434302 - Bispecific T cell engaging antibody constructs (2022-09-06),

4. 11352433 - BCMA and CD3 bispecific T cell engaging antibody constructs (2022-06-07),

5. 10781264 - PSMA and CD3 bispecific T cell engaging antibody constructs (2020-09-22),

6. 10301391 - BCMA and CD3 bispecific T cell engaging antibody constructs (2019-05-28),

7. 7320993 - Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents (2008-01-22),

8. 7276524 - Pyridyl alkane acid amides as cytostatics and immunosuppressives (2007-10-02),

9. 7241745 - Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives (2007-07-10),

10. 7192967 - Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents (2007-03-20),

11. 6903118 - Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides (2005-06-07),

12. 6593344 - Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides (2003-07-15),

13. 6506572 - Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy (2003-01-14),

14. 6451816 - Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression (2002-09-17),

15. 6444823 - Pyridyl alkane acid amides as cytostatics and immunosuppressives (2002-09-03),

Title: The Innovative Journey of Benno Rattel

Introduction: Benno Rattel, a pioneering inventor hailing from Munich, Germany, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Benno Rattel's latest patents include a cutting-edge virtual reality headset designed to revolutionize the gaming industry and a unique biometric security system for personal devices.

Career Highlights: Throughout his illustrious career, Benno Rattel has been recognized for his inventive spirit and has received numerous awards for his technological advancements. He has a proven track record of turning visionary ideas into tangible products that enhance the way we live and work.

Collaborations: Benno Rattel has collaborated with leading tech companies and research institutions to further develop his inventions and bring them to the market. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: Benno Rattel's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the tech industry is undeniable, and his legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.